GLP-1 Injectable Use Among Adults with Diagnosed Diabetes: United States, 2024

Vahratian, Anjel; Warren, Antonia

doi:10.15620/cdc/174616

i

GLP-1 Injectable Use Among Adults with Diagnosed Diabetes: United States, 2024

Public Domain

File Language:

English

Details

Personal Author:

Vahratian, Anjel ; Warren, Antonia
Corporate Authors:

National Center for Health Statistics (U.S.)
Description:

This report describes the percentage of adults with diagnosed diabetes who were taking an injectable glucagon-like peptide-1 (GLP-1) receptor agonist at the time of the interview by selected characteristics based on data from the 2024 National Health Interview Survey (NHIS).
Subjects:

Adult Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2 GLP-1 Glucagon-Like Peptide-1 Receptor Agonists Glucagon-Like Peptide 1 Glycemic Control Incretins
Keywords:

Dulaglutide, Glycemic Control, Incretin Mimetics, National Health Interview Survey Semaglutide,
Source:

National Health Interview Survey
Series:

NCHS Data Briefs
DOI:

https://dx.doi.org/10.15620/cdc/174616
Document Type:

Report
Genre:

Statistics
Place as Subject:

United States
Pages in Document:

7 Pages
Issue:

537
Collection(s):

National Center for Health Statistics
Main Document Checksum:

urn:sha-512:38ae4ecd7b95b848cbe98b97ea8fce1430c9e8d189256b2122dba46ea61e41e58252af5405b87e8097e80460c5f01a4f1ba65f341c8df296fdca4ecebe47981f
Download URL:

https://stacks.cdc.gov/view/cdc/174616/cdc_174616_DS1.pdf
File Type:

[PDF - 368.54 KB ]

File Language:

English

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.